Blood test can detect rejection of transplanted kidney

03/16/2012 | MedCityNews.com

A new molecular blood test uses RNA genetic markers to detect signs of renal failure following a kidney transplant. The test, which can identify kidney failure weeks before clinical symptoms manifest, can serve as a safer alternative to a renal biopsy, which can lead to graft injury or loss or bleeding, according to Quest Diagnostics.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID